What is the appropriate test to diagnose a suspected urinary fungal infection (candiduria)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Testing for Urinary Fungal Infection

For suspected urinary fungal infection (candiduria), obtain a freshly voided urine sample for microscopy and culture, which remain the cornerstone diagnostic tests, with species identification mandatory for all positive cultures. 1, 2

Primary Diagnostic Approach

Urine Microscopy and Culture

  • Collect freshly obtained urine from the bladder and process it with both microscopy and culture on selective fungal media. 1, 3
  • Microscopy can identify both yeasts and pseudohyphae, which serve as clinical signs of fungal UTI, though this finding alone does not distinguish infection from colonization. 1, 3
  • Culture on selective media is essential to avoid bacterial overgrowth and to confirm viable fungal organisms. 1, 4
  • No validated colony count threshold exists for fungal UTI - the traditional bacterial cutoff of 10^5 CFU/mL does not apply to Candida, and concentrations >10^3/mm^3 are typically considered significant in the appropriate clinical context. 5, 6

Species Identification is Mandatory

  • All positive cultures must undergo species identification, as different Candida species have vastly different antifungal susceptibility patterns. 1, 2, 7
  • C. glabrata exhibits inherently reduced azole susceptibility, making species identification critical for treatment decisions. 7, 4
  • Antifungal susceptibility testing is recommended for all isolates from symptomatic patients, especially in recurrent or complicated cases and those with prior azole exposure. 1, 7

Special Considerations for Catheterized Patients

Critical Diagnostic Limitations

  • In patients with indwelling urinary catheters, standard urine culture gives >50% false-negative results for biofilm infections. 1
  • Freshly obtained bladder urine should still be processed as in non-catheterized patients, but clinicians must recognize the high false-negative rate. 1
  • Examination of removed catheters or stents is necessary for definitive detection of biofilm infection, though routine examination of all removed catheters is not recommended. 1

Adjunctive Diagnostic Tests

Beta-D-Glucan (BDG) Testing

  • BDG testing is recommended when invasive candidiasis is suspected, as it can detect infection days to weeks before positive cultures. 2, 7
  • The test has 75-80% sensitivity and 80% specificity for invasive candidiasis. 7
  • BDG is particularly useful in critically ill patients where candiduria may be a marker for disseminated infection. 2, 6

Imaging Studies

  • Renal ultrasonography is the preferred initial imaging study in symptomatic or critically ill patients with candiduria to evaluate for pyelonephritis, abscess, or obstruction. 6
  • CT imaging is superior to ultrasound for detecting pyelonephritis or perinephric abscess. 1, 6
  • Imaging is not routinely indicated for simple cystitis but should be obtained if symptoms persist beyond 72 hours or if upper tract involvement is suspected. 1, 6

Tests NOT Recommended

Molecular and Novel Diagnostics

  • PCR-based and molecular techniques cannot distinguish true infection from asymptomatic bacteriuria and lack clinical validation for urinary fungal infections. 1
  • These tests cannot determine bacterial viability or quantitation, which are crucial for differentiating colonization from infection. 1
  • Molecular diagnostics may lead to overtreatment by detecting clinically insignificant organisms. 1

Echinocandins and Non-Fluconazole Azoles

  • Echinocandins achieve negligible urinary concentrations and should not be used for lower urinary tract Candida infections. 2, 4, 8

Common Diagnostic Pitfalls

Distinguishing Infection from Colonization

  • Most candiduria represents asymptomatic colonization rather than true infection - treatment decisions must be based on clinical context, not culture results alone. 2, 4, 6
  • Pyuria is nonspecific and does not reliably distinguish infection from colonization. 6
  • Simply removing an indwelling catheter eliminates candiduria in 40-50% of asymptomatic patients without antifungal therapy. 2, 8

When Discrepant Results Occur

  • Microscopy may be positive when culture is negative because microscopy detects both viable and non-viable cells. 9
  • Negative cultures do not exclude infection, as some Candida species require 5-14 days to grow. 9
  • Consider repeat testing with longer incubation times if clinical suspicion remains high despite negative initial cultures. 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Candida Urinary Tract Infection with Urinary Retention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Management of fungal urinary tract infections].

Presse medicale (Paris, France : 1983), 2007

Research

Candida urinary tract infections--diagnosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011

Guideline

Diagnostic Approach for Systemic C. glabrata Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Candida urinary tract infections: treatment options.

Expert review of anti-infective therapy, 2007

Guideline

Understanding Discrepant Candida Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.